Sandu Pharmaceuticals logo

Sandu Pharmaceuticals share news, announcements and annual reports

BSE: 524703Pharmaceuticals & BiotechnologySmall Cap

Sandu Pharmaceuticals Ltd. · Face value ₹10 · Listed Dec 1994
Last close ₹35.95up ₹0.64 (1.81%)

Share price at the BSE close on 30 Oct 2026. Previous close ₹35.31.

30 Oct: open ₹35.56, high ₹36.40, low ₹35.01

52-week range of traded prices to 30 Oct 2026
₹30.00Low, 30 Mar 2026₹50.00High, 27 Apr 2026
Market cap
₹35 Cr3,677th largest listed
P/E
19.61
P/B
0.80
Dividend yield
2.78%
ROE
4.1%
ROCE
5.3%
Debt to equity
0.01
Volume, BSE
2,591

Sandu Pharmaceuticals share news and announcements

659 announcements, routine notices left out, newest first. Page 10 of 14.

  1. Apr 2019

    • 16 Apr · Statement Of Investor Complaints For The Quarter Ended March 2019

      No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 2 1 1
    • 13 Apr · Statement Of Investor Complaints For The Quarter Ended March 2019

      No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 1 1 0
    • 11 Apr · Shareholding for the Period Ended March 31, 2019

      Shareholding Pattern for the Period Ended March 31, 2019. For more details, kindly Click ....
    • 11 Apr · Compliance Certificate For The Half Year Ended 31St March 2019

  2. Mar 2019

  3. Feb 2019

  4. Jan 2019

  5. Nov 2018

  6. Oct 2018

  7. Sep 2018

  8. Aug 2018

  9. Jul 2018

    • 10 Jul · Shareholding for the Period Ended June 30, 2018

      Shareholding Pattern for the Period Ended June 30, 2018. For more details, kindly Click ....
    • 10 Jul · Statement Of Investor Complaints For The Quarter Ended June 2018

      No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
  10. Jun 2018

  11. May 2018

  12. Apr 2018

  13. Mar 2018

  14. Feb 2018

  15. Jan 2018

  16. Dec 2017

  17. Nov 2017

  18. Oct 2017